{"id":10821,"date":"2026-07-30T15:40:55","date_gmt":"2026-07-30T10:10:55","guid":{"rendered":"https:\/\/indianpharmanetwork.co.in\/medicines\/?post_type=product&p=10821"},"modified":"2026-07-30T17:00:52","modified_gmt":"2026-07-30T11:30:52","slug":"kopozgo-mavacamten-get-access-india","status":"publish","type":"product","link":"https:\/\/indianpharmanetwork.co.in\/medicines\/product\/kopozgo-mavacamten-get-access-india\/","title":{"rendered":"Kopozgo (Mavacamten) Capsules"},"content":{"rendered":"
Mavacamten is indicated for the treatment of adults with symptomatic New York Heart Association class II-III obstructive hypertrophic cardiomyopathy to improve functional capacity and symptoms.<\/div>\n
<\/div>\n
Obstructive hypertrophic cardiomyopathy is an inherited and often progressive heart disease that can cause symptoms such as shortness of breath, fatigue, and dizziness, and in severe cases lead to heart failure, arrhythmias, stroke, or sudden cardiac death. Affecting nearly 1 in 500 people globally, the condition may impact up to 2.8 million people in India, with nearly 80 to 90 per cent remaining undiagnosed.<\/div>\n
\n
\n

Globally, Mavacamten received its first approval from the U.S. Food and Drug Administration (FDA) in April 2022, followed by the European Union in June 2023, and is now authorised in more than 50 countries.<\/p>\n<\/div>\n<\/div>\n

\n

Is Kopozgo (Mavacamten) available in India?<\/h4>\n

Bristol Myers Squibb (BMS) has launched Kopozgo (Mavacamten) in India, the first and only oral, selective cardiac myosin inhibitor approved for adults with symptomatic New York Heart Association (NYHA) Class II\u2013III obstructive hypertrophic cardiomyopathy (oHCM).<\/p>\n

How to get Kopozgo Capsules delivered in India?<\/h4>\n

Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations.<\/strong>\u00a0Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.<\/p>\n

IPN having representation in<\/strong>\u00a0Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.<\/p>\n

Who can help source Kopozgo Capsules in India legally?<\/h4>\n

Named-patient import facilitator contact details<\/strong>
\nCompany Name:<\/strong>\u00a0Indian Pharma Network (IPN)
\nAddress:<\/strong>\u00a060\/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
\nFor sourcing and import coordination of specialty medicines, contact:<\/strong>
\nMr. Tarun:<\/strong>\u00a0+91 9891 296 838
\nMr. Neeraj:<\/strong>\u00a0+91 9811 747 774
\nEmail:\u00a0info@indianpharmanetwork.co.in<\/a><\/strong><\/p>\n

Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.<\/em><\/p>\n<\/div>\n

NEWS \/ UPDATES<\/strong><\/div>\n
\n
<\/div>\n